Our results indicate abundance of FoxP3+ Tregs in non-treated glioma, whereas a significant reduction in intratumoral FoxP3+ Tregs is observed with CPMV immunotherapy (Figure 4B). The gene discussed is FOXP3; the disease is glioma.